000 01320 a2200373 4500
005 20250513082329.0
264 0 _c19930621
008 199306s 0 0 eng d
022 _a0393-6155
024 7 _a10.1177/172460089300800101
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEpenetos, A A
245 0 0 _aNew molecular targets and therapeutic strategies against cancer.
_h[electronic resource]
260 _bThe International journal of biological markers
_c
300 _a1-7 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aChromosomes, Human, Pair 17
650 0 4 _aErbB Receptors
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xgenetics
650 0 4 _aGenes, Retinoblastoma
650 0 4 _aGenes, p53
650 0 4 _aGenes, ras
_xdrug effects
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xchemistry
650 0 4 _aProto-Oncogenes
650 0 4 _aVaccines
700 1 _aLinardou, H
773 0 _tThe International journal of biological markers
_gvol. 8
_gno. 1
_gp. 1-7
856 4 0 _uhttps://doi.org/10.1177/172460089300800101
_zAvailable from publisher's website
999 _c8495899
_d8495899